Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
9h
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
AbbVie Humira, Pfizer/BioNTech COVID-19 shot may not make top 10 pharma drugs in 2024, with Novo Nordisk Ozempic and ...
Daily
18h
Sanofi, Regeneron get USFDA nod for Dupixent for COPD
Paris: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on ...
20h
Regeneron: Long-Term Defensive Investment
Regeneron's R&D expenses are projected to reach $5 billion, but the business remains highly profitable. Read why I rate REGN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Helene death toll rises
Actor John Ashton dies
ISR airstrike kills Qaouk
'Days of Our Lives' star dies
Vance’s Pennsylvania rally
Hospitalized for burns
Rescue mission launched
'SNL' launches 50th season
NC small plane crash
Malibu coast earthquake
Temporary outage fixed
Earth's orbit new asteroid
Trump to visit Fayetteville
Ukrainian drones shot down
Szarewicz case update
Steward CEO to step down
Chief adviser subpoenaed
Congestion fee bid denied
ISR strikes Lebanon again
Faces fine to end Brazil ban
On Hezbollah leader's killing
Condemns Israeli strikes
Haney sues Garcia
Dow closes at record high
‘Wild Robot' tops box office
Ga. chemical plant fire
121st loss of the season
Congressional Gold Medal
Houthis attack US warships
UNC digital IDs blocked
Human rabies death in MN
AL sued over purging voters
Related topics
Sanofi
Regeneron
China
United States
Food and Drug Administration
Feedback